ReShape Lifesciences ROE 2015-2024 | RSLS
Current and historical return on equity (ROE) values for ReShape Lifesciences (RSLS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ReShape Lifesciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $-0.01B | $0.00B | -355.56% |
| 2024-09-30 | $-0.01B | $0.00B | -200.00% |
| 2024-06-30 | $-0.01B | $0.00B | -222.22% |
| 2024-03-31 | $-0.01B | $0.01B | -200.00% |
| 2023-12-31 | $-0.01B | $0.01B | -192.00% |
| 2023-09-30 | $-0.03B | $0.00B | -472.73% |
| 2023-06-30 | $-0.03B | $0.01B | -340.00% |
| 2023-03-31 | $-0.04B | $0.01B | -246.15% |
| 2022-12-31 | $-0.05B | $0.00B | -187.50% |
| 2022-09-30 | $-0.07B | $0.02B | -194.12% |
| 2022-06-30 | $-0.07B | $0.03B | -148.45% |
| 2022-03-31 | $-0.07B | $0.04B | -121.82% |
| 2021-12-31 | $-0.06B | $0.04B | -134.03% |
| 2021-09-30 | $-0.04B | $0.08B | -86.96% |
| 2021-06-30 | $-0.02B | $0.06B | -100.00% |
| 2021-03-31 | $-0.02B | $0.01B | -237.84% |
| 2020-12-31 | $-0.02B | $0.01B | -231.58% |
| 2020-09-30 | $-0.02B | $0.01B | -190.00% |
| 2020-06-30 | $-0.02B | $0.01B | -133.33% |
| 2020-03-31 | $-0.02B | $0.01B | -152.73% |
| 2019-12-31 | $-0.02B | $0.02B | -188.24% |
| 2019-09-30 | $-0.03B | $0.02B | -233.33% |
| 2019-06-30 | $-0.03B | $0.01B | -258.33% |
| 2019-03-31 | $-0.03B | $0.01B | -242.86% |
| 2018-12-31 | $-0.04B | $0.01B | -208.22% |
| 2018-09-30 | $-0.04B | $0.02B | -164.21% |
| 2018-06-30 | $-0.04B | $0.02B | -137.82% |
| 2018-03-31 | $-0.04B | $0.02B | -101.96% |
| 2017-12-31 | $-0.04B | $0.04B | -75.27% |
| 2017-09-30 | $-0.03B | $0.04B | -59.53% |
| 2017-06-30 | $-0.03B | $0.05B | -64.37% |
| 2017-03-31 | $-0.02B | $0.06B | -72.73% |
| 2016-12-31 | $-0.02B | $0.06B | -106.67% |
| 2016-06-30 | $-0.01B | $0.01B | -600.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.005B | $0.008B |
| ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA. | |||